Page 47 - 74_01

VOL. 74 (1), 29-50, 2008 PARASITOSIS Y CÁNCER

(13) nol, thiopurinol ribonucleoside, and formycin B, sinefungin and the lepidine
(14) WR6026. Trans. R. Soc. Trop. Med. Hyg. 79: 122-128.
(15) ALVAR, J.; ROCHE, J.; SARION, A.; RAMOS, M. C. y BENITO, A. (1999): Tratamiento
(16) de las enfermedades intestinales causadas por protozoos y coccidios. Rev.
(17) Esp. Quim. 12: 120-125.
WANG, C. C. (1995): Molecular Mechanism and Therapeutic Approaches to
(18) the treatment of African Tripanosomiasis. Annu. Rev. Pharmacol. Toxicol. 35:
(19) 93-127.
SAVEL, J. y DURAN, R. (2001): Dihydrofolate Reductase inhibitors: New De-
(20) velopments in in Antiparasitic Chemotherapy. Exp. Op. Ther. Pat. 11: 1285-
(21) 1290.
BRAÑA, M. F.; CACHO, M. y GUISADO, C. (2006): Sulfonamida el grupo mágico.
(22) An. R. Acad. Nac. Farm. 72: 317-341.
(23) PHELPS, P. C.; BEST, C. J.; BEREZESKY, I. K.; MERRIMAN, R. L.; TANZER, L. R.;
(24) BODER, G. B. y TRUMP, B. F. (1995): Studies on the Mechanism of sulofenur
(25) and LY295501 Toxicity: Effect on the Regulation of Cytosolic Calcium in
(26) relation to Cytotoxicity in Normal and Tumorigenic Rat Kidney Cell Lines.
Cancer Lett. 97: 7-15. CASINI, A.; SCOZZAFAVA, A. y SUPURAN, C. T. (2002): Sul-
fonamide Derivatives with Protease Inhibitory Action as Anticancer, Antiin-
flammatory and Antiviral Agents. Exp. Op. Ther. Pat. 12: 1307-1327.
OLTERSDORF, T.; ELMORE, S. W.; SHOEMAKER, A. R.; ARMSTRONG, R. C.; AUGER, D.,
et al. (2005): An Inhibitor of Bcl-2 Family Proteins induces regresión of Solid
Tumor. Nature 435: 677-681.
ROSEN, P. J.; MENDOZA, E. F.; LANDAW, E. M.; MONDINO, B.; GRAVES, M. C.;
MCBRIDE, J. H.; TURCILLO, P.; DE KERNION, J. y BELLDEGRUN, A. (1996): Suramin
in Hormone-Refractory Metastatic Prostate Cancer: a Drug with Limited Effi-
cacy. J. Clin. Oncol. 14: 1626-1636.
GRUEIRO, M. M. (2002): Cribado Antihemíntico Primario: Sistemas para la
Evaluación in vitro. Analecta Vet. 22: 32-49.
BRODFUEHRER, J. I.; WILKIE, T. J.; KINDER, D. H. y POWIS, G. (1988): Preclinical
Pharmacologic Studies of the New Antitumor Agent Carmethizole (NSC-
602668) in the Mouse and Beagle Dog. Cancer Chemother. Pharmacol. 24:
277-283.
MILANO, M. C.; WAINSTEIN, R.; GARCÍA, C. A. y TOMADONI, A. E. (1996): Colorec-
tal cancer: surgery or is there something else? Medicine. 56: 423-428.
WEINBACH, E. C. y GARBUS, J. (1969): Mechanism of Action of Reagents that
Unecouple Oxidative Phosphorilation. Nature. 221: 1016-1018.
SENDEROWICZ, A. M. (1999): Flavopiridol: the First Cyclin-Dependent Kinase
Inhibitor in Human Clinical Trials. New Drugs. 17: 313-320.
BRAÑA, M. F. (2005): Hipoxia: una diana terapéutica (Editorial) Clin. Transl.
Oncology. 7: 475-476.
DISCHE, S.; SAUNDERS, M. I.; BENNETT, M.; DUNPHY, E. P.; DES ROCHES, C.; STRAT-
FORD, M. R.; MINCHINTON, A. I. y WARDMAN, P. (1986): A Comparison of the
Tumour Concentrations Obtainable with Misonidazile and Ro 03-8799.
Brt. J. Radiology. 59: 911-917.

49